Evoke Receives Favorable Response From U.S. Food and Drug Administration Regarding Pediatric Study Plan for EVK-001 Read more about Evoke Receives Favorable Response From U.S. Food and Drug Administration Regarding Pediatric Study Plan for EVK-001
Evoke Pharma Reports Second Quarter 2015 Results Read more about Evoke Pharma Reports Second Quarter 2015 Results
Evoke Pharma Schedules Webcast and Conference Call for Second Quarter 2015 Financial Results Read more about Evoke Pharma Schedules Webcast and Conference Call for Second Quarter 2015 Financial Results
Evoke Pharma to Present at Cantor Fitzgerald Inaugural Healthcare Conference Read more about Evoke Pharma to Present at Cantor Fitzgerald Inaugural Healthcare Conference
Evoke Pharma Announces Publication of Clinical Data Demonstrating EVK-001 Significantly Improves Symptoms in Women With Diabetic Gastroparesis Read more about Evoke Pharma Announces Publication of Clinical Data Demonstrating EVK-001 Significantly Improves Symptoms in Women With Diabetic Gastroparesis
Evoke Pharma Reports First Quarter 2015 Results Read more about Evoke Pharma Reports First Quarter 2015 Results
Evoke Pharma Schedules Webcast and Conference Call for First Quarter 2015 Financial Results Read more about Evoke Pharma Schedules Webcast and Conference Call for First Quarter 2015 Financial Results
Evoke Pharma Achieves Significant Manufacturing Milestone With Successful Completion of Commercial Scale Production of EVK-001 Read more about Evoke Pharma Achieves Significant Manufacturing Milestone With Successful Completion of Commercial Scale Production of EVK-001
Evoke Pharma Granted European Union Formulation Patent for EVK-001 Read more about Evoke Pharma Granted European Union Formulation Patent for EVK-001
Evoke Pharma Reports Fourth Quarter and Year End 2014 Results Read more about Evoke Pharma Reports Fourth Quarter and Year End 2014 Results